Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What’s New in This Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights
Market Outlook
Market Summary

Chapter 3 Market Overview
Introduction
Pluripotency Factors
Research and Therapeutic Significance

Chapter 4 Market Dynamics
Market Drivers
Growing Research and Development in iPSCs
Increased Investment in Biotechnology Industry
Rising Prevalence of Chronic Diseases
Use of iPSCs in Precision Medicine

Chapter 5 Induced Pluripotent Stem Cell Applications
Academic Research
Pharmaco-toxicological Screening
Drug Discovery and Development
Disease Modeling
Tissue Engineering
Cell Therapy
Emerging Technologies

Chapter 6 Induced Pluripotent Stem Cell Market Segmentation and Forecast
Market Overview
U.S.
Europe
Asia-Pacific
Generation of Induced Pluripotent Stem Cells
Application-based Market Overview
Induced Pluripotent Stem Cells Product Market
Induced Pluripotent Stem Cell-derived Tissue Cell Market
Challenges
Induced Pluripotent Stem Cells and Their Derivative Cell Market, by Species
Global Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Market for Induced Pluripotent Stem Cell-derived Cells, by Application
Market for Induced Pluripotent Stem Cells, by Product Function
Global Market
Regional Markets
Market for Induced Pluripotent Stem Cells, by End Use

Chapter 7 Induced Pluripotent Stem Cells Research Application Market
Induced Pluripotent Stem Cells Research Product Types
Major Players
Major Commercial Entities
Major Noncommercial Organizations
Market Shares and Projections

Chapter 8 Induced Pluripotent Stem Cell Contract Service Market
Induced Pluripotent Stem Cell Contract Service Types
Major Players
Market Shares and Projections

Chapter 9 Clinical Application Market Trend Analysis
Clinical Trials
Age-related Macular Degeneration
Ischemic Heart Disease
Parkinson’s Disease
Graft-versus-host Disease (GvHD)
Spinal Cord Injuries
Corneal Repair
Cancer
Driving Forces
Limiting Factors
Technologies
Regulations
Market Acceptance
Clinical Efficiency

Chapter 10 Competitive Landscape
Mergers and Acquisitions
Strategic Alliances

Chapter 11 Company Profiles
ADDGENE
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
ALSTEM
APPLIED BIOLOGICAL MATERIALS INC. (ABM)
APPLIED STEMCELL INC.
ATCC
AXOL BIOSCIENCE LTD.
BIO-TECHNE CORP.
BLUEROCK THERAPEUTICS
BRISTOL MYERS SQUIBB (IPIERIAN)
CELL SIGNALING TECHNOLOGY (CST)
CORNING INC.
CREATIVE BIOARRAY?
FATE THERAPEUTICS
FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
GENECOPOEIA INC.
GENTARGET INC.
ID PHARMA CO. LTD.
INVIVOGEN
LONZA GROUP LTD.
MEGAKARYON CORP.
MERCK KGAA
NCARDIA
NEWCELLS BIOTECH
PEPROTECH INC.
PLASTICELL LTD.
PROMEGA CORP.
PROMOCELL GMBH
QIAGEN NV
REPROCELL INC.
SCIENCELL RESEARCH LABORATORIES
STEMCELL TECHNOLOGIES?
SYSTEM BIOSCIENCES INC.
TAKARA BIO USA INC. (CLONTECH LABORATORIES)
THERMO FISHER SCIENTIFIC
VERTEX PHARMACEUTICALS INC.
WAISMAN BIOMANUFACTURING

Chapter 12 Appendix: Acronyms



List of Tables


Summary Table : Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028
Table 1 : Global Market for Induced Pluripotent Stem Cells, by Region, Through 2028
Table 2 : U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2028
Table 3 : European Market for Induced Pluripotent Stem Cells, by Country, Through 2028
Table 4 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2028
Table 5 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028
Table 6 : Global Market for Induced Pluripotent Stem Cells, by Method, Through 2028
Table 7 : Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 8 : U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 9 : European Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 10 : Asia-Pacific Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 11 : Rest of the World Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 12 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, Through 2028
Table 13 : Global Market for Induced Pluripotent Stem Cell-derived Cells, by Species, Through 2028
Table 14 : Major Commercial Suppliers of Induced Pluripotent Stem Cell Products, by Country
Table 15 : Major Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country
Table 16 : Global Market for Induced Pluripotent Stem Cell-derived Cells, by Application, Through 2028
Table 17 : Global Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 18 : U.S. Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 19 : European Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 20 : Asia-Pacific Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 21 : RoW Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 22 : Global Market for Induced Pluripotent Stem Cells, by End Use, Through 2028
Table 23 : Global Market for Induced Pluripotent Stem Cell-related Products, by Function, Through 2028
Table 24 : Major University and Institute Facilities for Induced Pluripotent Stem Cell Research, by Location/Country
Table 25 : Major Companies Providing iPSC Contract Services, by State/Country
Table 26 : Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2028
Table 27 : Induced Pluripotent Stem Cells Pipeline (Interventional Trials)*
Table 28 : Bio-Techne: Annual Financials/Revenue, 2022
Table 29 : Bristol Myers Squibb: Financials/Revenue, 2022
Table 30 : Corning Inc.: Financials/Revenue, 2022
Table 31 : Qiagen NV: Annual Financials/Revenue, 2022
Table 32 : Thermo Fisher Scientific: Annual Financials/Revenue, 2022
Table 33 : Acronyms Used in the iPSCs Industry